论文部分内容阅读
目的:研究地塞米松治疗婴儿肝炎综合征的应用疗效。方法:选择2011年5月~2013年5月于我院治疗的48例婴儿肝炎综合征患者,随机分为实验组和对照组2组,实验组在常规治疗的基础上采用地塞米松注射,对照组进行常规治疗。观察2组婴儿的肝功能指标情况。结果:实验组即采用地塞米松的婴儿总胆红素(TBIL)、直接胆红素(DBIL)、总胆汁酸(TBA)谷丙转氨酶(ALT)的含量均低于对照组,且差异有统计学意义(P<0.05)。结论:与常规治疗的方法相比,地塞米松更有利于治疗婴儿肝炎综合征,值得临床进一步研究推广。
Objective: To study the therapeutic effect of dexamethasone on infant hepatitis syndrome. Methods: 48 cases of infantile hepatitis syndrome treated in our hospital from May 2011 to May 2013 were randomly divided into experimental group and control group. The experimental group received dexamethasone injection on the basis of routine treatment, Control group for routine treatment. Two groups of infants were observed liver function indicators. Results: The levels of total bilirubin (TBIL), direct bilirubin (DBIL) and total alanine aminotransferase (ALT) in dexamethasone group were lower than those in control group Statistical significance (P <0.05). Conclusion: Compared with the conventional treatment, dexamethasone is more conducive to the treatment of infantile hepatitis syndrome, it is worth further study to promote clinical.